Use of Fractional Factorial Designs in Antiviral Drug Studies

Experimental design and analysis is an effective and commonly used tool in scientific investigations and industrial applications. Many successful applications have been reported in engineering domains, such as chemical engineering, electrical engineering, and mechanical engineering. However, few cases have been reported in biological research, particularly in virology study. Antiviral drug combinations are increasingly used to reduce possible drug-resistant viral mutant and reduce cytotoxicity. Drug combinations have often been reported to have higher efficacy and lower individual drug dosage. However, the combined antiviral drug effect is generally hard to assess. One important reason is due to the complex interactions between biological systems and drug molecules. We report a study using fractional factorial designs to investigate a biological system with Herpes simplex virus type 1 and five antiviral drugs. The experiment uses a novel composite design that consists of a 16-run fractional factorial design and an 18-run orthogonal array. The results indicate that two chemical drugs, Ribavirin and Acyclovir, are more effective than three Interferon drugs. Furthermore, significant interactions exist within the Interferon drug group and within the Ribavirin-Acyclovir chemical drug group, but the interactions between the Interferon group and the chemical group are not significant. These observations have major implications in the understanding of antiviral drug mechanism towards better design of combinatorial antiviral drug therapy. Copyright © 2012 John Wiley & Sons, Ltd.

[1]  Connie Celum,et al.  Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. , 2007, The Journal of infectious diseases.

[2]  M. Fellous,et al.  A protein tyrosine kinase in the interferon α β signaling pathway , 1992, Cell.

[3]  G. Ramadori,et al.  Ribavirin inhibits DNA, RNA, and protein synthesis in PHA‐stimulated human peripheral blood mononuclear cells: Possible explanation for therapeutic efficacy in patients with chronic HCV infection , 2003, Journal of medical virology.

[4]  A. Ricci,et al.  Herpes simplex pneumonia: Combination therapy with oral acyclovir and aerosolized ribavirin in an immunocompetent patient. , 2004, Current therapeutic research, clinical and experimental.

[5]  Erik De Clercq,et al.  Antiviral drugs in current clinical use. , 2004 .

[6]  R. Whitley,et al.  Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Håvard Jenssen,et al.  Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. , 2003, Antiviral research.

[8]  M. Croxson,et al.  Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome , 1997, Journal of neurology, neurosurgery, and psychiatry.

[9]  K. Rosenthal,et al.  Multiple mechanisms for HSV-1 induction of interferon α production by peripheral blood mononuclear cells , 2003, Archives of Virology.

[10]  Fujie Xu,et al.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. , 2006, JAMA.

[11]  Max D. Morris,et al.  A Class of Three-Level Experimental Designs for Response Surface Modeling , 2000, Technometrics.

[12]  S Hercberg,et al.  Seroprevalence of HSV-1 and HSV-2 infection in the general French population , 2002, Sexually transmitted infections.

[13]  Subhajit Biswas,et al.  Drug resistance mutations in HSV-1 UL5 selected using a helicase–primase inhibitor: frequency and effects on virus growth and pathogenicity , 2009 .

[14]  John Norrie,et al.  Longitudinal study of genital infection by herpes simplex virus type 1 in western Scotland over 15 years , 2002, BMJ : British Medical Journal.

[15]  Weng Kee Wong,et al.  Recent developments in nonregular fractional factorial designs , 2008, 0812.3000.

[16]  C. F. Jeff Wu,et al.  Optimal Projective Three-Level Designs for Factor Screening and Interaction Detection , 2004, Technometrics.

[17]  W. Halford,et al.  Alpha/Beta Interferon and Gamma Interferon Synergize To Inhibit the Replication of Herpes Simplex Virus Type 1 , 2002, Journal of Virology.

[18]  J. Shaw,et al.  Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication , 1980, Journal of virology.